Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3561654
Max Phase: Preclinical
Molecular Formula: C29H28F4N4O5
Molecular Weight: 474.54
Molecule Type: Small molecule
Associated Items:
ID: ALA3561654
Max Phase: Preclinical
Molecular Formula: C29H28F4N4O5
Molecular Weight: 474.54
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(NCCN1CCC2(CC1)C(=O)NCN2C(=O)c1cccc(F)c1)c1ccc2ccccc2c1.O=C(O)C(F)(F)F
Standard InChI: InChI=1S/C27H27FN4O3.C2HF3O2/c28-23-7-3-6-22(17-23)25(34)32-18-30-26(35)27(32)10-13-31(14-11-27)15-12-29-24(33)21-9-8-19-4-1-2-5-20(19)16-21;3-2(4,5)1(6)7/h1-9,16-17H,10-15,18H2,(H,29,33)(H,30,35);(H,6,7)
Standard InChI Key: XYLLRLIJACFXKM-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 474.54 | Molecular Weight (Monoisotopic): 474.2067 | AlogP: 2.77 | #Rotatable Bonds: 5 |
Polar Surface Area: 81.75 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 11.07 | CX Basic pKa: 7.49 | CX LogP: 2.37 | CX LogD: 2.02 |
Aromatic Rings: 3 | Heavy Atoms: 35 | QED Weighted: 0.60 | Np Likeness Score: -1.25 |
1. PubChem BioAssay data set, |
Source(1):